Autoantibodies to the Insulin Receptor: EFFECT ON THE INSULIN-RECEPTOR INTERACTION IN IM-9 LYMPHOCYTES
AUTOR(ES)
Flier, Jeffrey S.
RESUMO
The serum of some patients with insulin-resistant “diabetes” contains antibodies that bind to and block the cell membrane receptors for insulin. In this report, we have characterized the effects of the antireceptor antibodies on the interaction of 125I-insulin with its receptor on the human lymphoblastoid cell line IM-9. Up to 95% of specific insulin binding can be inhibited by pretreatment of the cells with these immunoglobulins. The onset of the inhibitory effect is time- and temperature-dependent, and the effect is reversed extremely slowly if the cells are suspended in a large excess of antibody-free buffer. These features of antibody binding can be easily distinguished from those for insulin binding to its receptor. The inhibitory effect of the antibodies can be reversed by exposure of the cells to conditions known to elute surface immunoglobulins.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=372426Documentos Relacionados
- Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes.
- Glucocorticoid regulation of insulin receptor gene transcription in IM-9 cultured lymphocytes.
- Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance.
- Insulin-Receptor Interactions in Adipose Tissue Cells: Direct Measurement and Properties
- Increased Clearance and Degradation of [3H]Insulin in Streptozotocin Diabetic Rats: ROLE OF THE INSULIN-RECEPTOR COMPARTMENT
